Lupin Pharmaceuticals, Inc.
Lupin has now recorded 8 consecutive years of strong growth, making it the 14th largest generic pharmaceutical company in the world by revenue. Lupin is dedicated to delivering high-quality branded and generic medications, trusted by health care professionals and patients across the US, making it the 5th largest generic manufacturer in the US (by prescriptions) and one of the fastest-growing generic pharmaceutical companies in the US. The continuous growth can be attributed to a strong pipeline, solid customer relationships, and flawless execution.
Lupin’s sustained growth in revenue stems from a culmination of entities. It has forged a unique growth strategy for the Advanced Markets built around quality niche products, world-class research, manufacturing, and supply chain capabilities. Lupin recognizes the importance of R&D and has invested 7.5% of its FY 2012 net sales in this area. In FY 2013, the US Generics business reported growth of 52%, with revenues of $548 million USD, up from $361 million USD in FY 2012 (unaudited figures).
As the demands of the US generic pharmaceutical market continue to grow, so does Lupin. Lupin has expanded its manufacturing capabilities over the past several years with additional state-of-the art facilities to exceed customer demands and strengthen its overall supply chain by creating efficiencies that ensure a cutting-edge response time, thus creating unrivaled value. Lupin has earned its reputation as a global pharmaceutical company on the back of consistent and reliable delivery of high-quality products. Lupin’s customers trust the company to act responsibly and deliver safe and effective medications at affordable costs.
By the Numbers
- 58 total generic products- Launched 13 generic products in FY 2013- FY 2013 revenue of $548 million USD
Lupin’s global formulations business is built on the backbone of one of the most efficient API businesses in the world. Lupin is one of the most vertically integrated global generics companies and remains the leader in therapeutic areas such as cephalosporins, cardiovasculars, and anti-TB products.
The Lupin Flower
The company was named after the Lupin flower because of the inherent qualities of the flower and what it personifies and stands for. The Lupin flower is known to nourish the land: the very soil it grows in. The Lupin flower is also known to be tolerant of infertile soils and capable of pioneering change in barren and poor climates.
Lupin is a fully integrated pharmaceutical company with a major global presence. This presence was built on its platforms of cutting-edge research, world-class manufacturing facilities, and a truly global supply chain. With the building blocks in place, the future looks even brighter.
For more information, please visit www.lupinpharmaceuticals.com.